SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 48.89 |
| Enterprise Value ($M) | -69.40 |
| Book Value ($M) | 113.31 |
| Book Value / Share | 22.55 |
| Price / Book | 0.43 |
| NCAV ($M) | 113.31 |
| NCAV / Share | 22.55 |
| Price / NCAV | 0.43 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.52 |
| Return on Assets (ROA) | -0.31 |
| Return on Equity (ROE) | -0.40 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 22.63 |
| Current Ratio | 22.63 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 118.55 |
| Assets | 118.55 |
| Liabilities | 5.24 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -55.26 |
| Net Income | -58.77 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -67.70 |
| Cash from Investing | 95.00 |
| Cash from Financing | 0.02 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | EcoR1 Capital, LLC | 8.10 | -96.16 | |
| 13G | Octagon Capital Advisors LP | 9.70 | ||
| 13G/A | Invus Global Management, LLC | 5.70 | ||
| 13G/A | Gilead Sciences Inc | 14.60 | 21.39 | |
| 13G/A | Fmr Llc | 4.99 | -19.21 | |
| 13G/A | Artal International S.C.A. | 5.80 | 18.29 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 49 | 7,433 | 0.66 | |
| 1,068 | 2,741 | 38.96 | |
| 30 | 3,399 | 0.88 | |
| 175 | 3,298 | 5.31 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ALDX – Aldeyra Therapeutics, Inc. | ALGS – Aligos Therapeutics, Inc. |
| ALTS – JanOne Inc. | ALZN – Alzamend Neuro, Inc. |
| ANEB – Anebulo Pharmaceuticals, Inc. |
Financial data and stock pages provided by
Fintel.io